Reconsidering medication appropriateness for patients late in life

Archives of Internal Medicine

Volumn 166, Issue 6, 2006, Pages 605-609

  Holmes, Holly M ^a   Hayley, Déon Cox ^a   Alexander, G Caleb ^a   Sachs, Greg A ^a  

^a MC 6098 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ATORVASTATIN; CALCIUM; CHLORPROPAMIDE; FLUTICASONE PROPIONATE; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IPRATROPIUM BROMIDE; ISOSORBIDE MONONITRATE; LISINOPRIL; METOLAZONE; SALBUTAMOL SULFATE; SIMVASTATIN; THEOPHYLLINE;

ACUTE DISEASE; CANCER SCREENING; CLINICAL FEATURE; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; DEMENTIA; DIABETES MELLITUS; EMPHYSEMA; FUNCTIONAL DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY FAILURE; LIFE EXPECTANCY; MEDICAL ASSESSMENT; MEDICAL CARE; MEDICAL INFORMATION; NOTE; NURSING HOME; OSTEOARTHRITIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; DECISION MAKING; DRUG THERAPY; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; LIFE EXPECTANCY; MALE;

EID: 33645469743     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.6.605     Document Type: Note

References (22)

1. Smith SC Jr, Blair SN, Bonow RO, et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 2001;38:1581-1583.
2. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825-1832.
3. Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045-1051.
4. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716-2724.
5. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA. 2001;286:2823-2829.
6. Curtis LH, Ostbye T, Sendersky V, et al. Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med. 2004;164:1621-1625.
7. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001;285:2750-2756.
8. Fried LP, Kronmal RA, Newman AB, et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA. 1998;279:585-592.
9. Sachs GA. Dementia and the goals of care. J Am Geriatr Soc. 1998;46:782-783.
10. Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63:225-232.
11. Collins R, Armitage J, Parish S, et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361:2005-2016.
12. ETDRS Investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus: Early Treatment Diabetic Retinopathy Study report 14. JAMA. 1992;268:1292-1300.
13. National Hospice and Palliative Care Organization Medical guidelines for determining prognosis in selected non-cancer diseases. In: Hospice Care: A Physician's Guide. Alexandria, Va: National Hospice and Palliative Care Organization; 1998.
14. Vollrath AM, Sinclair C, Hallenbeck J. Discontinuing cardiovascular medications at the end of life: lipid-lowering agents. J Palliat Med. 2005;8:876-881.
15. Kravitz RL, Epstein RM, Feldman MD, et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA. 2005;293:1995-2002.
16. Straand J, Sandvik H. Stopping long-term drug therapy in general practice: how well do physicians and patients agree? Fam Pract. 2001;18:597-601.
17. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135:825-834.
18. Roland M. Linking physicians' pay to the quality of care - a major experiment in the United Kingdom. N Engl J Med. 2004;351:1448-1454.
19. Walter LC, Davidowitz NP, Heineken PA, Covinsky KE. Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA. 2004;291:2466-2470.
20. Somogyi-Zalud E, Zhong Z, Lynn J, Hamel MB. Elderly persons' last six months of life: findings from the Hospitalized Elderly Longitudinal Project. J Am Geriatr Soc. 2000;48(5)(suppl):S131-S139.
21. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. Representation of elderly persons and womenin published randomized trials of acute coronary syndromes. JAMA. 2001;286:708-713.
22. Graves T, Hanlon JT, Schmader KE, et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med. 1997;157:2205-2210.